Related Experiment Video
Updated: Jun 6, 2026
05:14
Standardized Data Acquisition for Neuromelanin-Sensitive Magnetic Resonance Imaging of the Substantia Nigra
Published on: September 8, 2021
[Metabolic syndrome in schizophrenia]
1Center for Psykiatrisk Forskning, Århus Universitetshospital, Risskov, 8240 Risskov, Denmark. lene.nyboe@ps.rm.dk
Ugeskrift for Laeger
|December 7, 2010
Summary
Metabolic syndrome (MetS) is a significant risk for cardiovascular disease and type 2 diabetes in schizophrenia patients. Early screening and interventions like lifestyle changes can effectively reduce MetS and improve health outcomes.
Area of Science:
- Psychiatry
- Metabolic Health
- Cardiovascular Disease
Background:
- Metabolic syndrome (MetS) is a cluster of conditions increasing cardiovascular disease and type 2 diabetes risk.
- Schizophrenia patients exhibit high prevalence of MetS, exacerbated by lifestyle factors and antipsychotic medications.
- MetS significantly contributes to premature mortality in individuals with schizophrenia.
Purpose of the Study:
- To review the prevalence and management of MetS in schizophrenia patients.
- To highlight the impact of lifestyle and medication on MetS development.
- To emphasize the benefits of early screening and intervention strategies.
Main Methods:
- Literature review of studies on MetS in schizophrenia.
- Analysis of pharmacological and non-pharmacological interventions.
- Evaluation of screening protocols and early intervention benefits.
Main Results:
- Unhealthy lifestyle and antipsychotic drugs are primary drivers of MetS in this population.
- Interventions including cognitive behavioral therapy, exercise, and diet show promise in mitigating MetS.
- Systematic screening and prompt intervention are crucial for risk reduction.
Conclusions:
- Early detection and management of MetS are vital for improving physical health in schizophrenia.
- A multi-faceted approach combining lifestyle modifications and appropriate therapies is recommended.
- Reducing MetS burden can decrease somatic disease and mortality rates in schizophrenia patients.
Related Concept Videos
01:29Psychological and Sociocultural Causes of Schizophrenia
Schizophrenia, a complex psychiatric disorder, has been historically misunderstood. Early psychological theories attributed its origins to childhood trauma and unresponsive parenting. However, contemporary research largely rejects these notions, favoring the vulnerability-stress hypothesis. This model proposes that individuals with a genetic predisposition to schizophrenia may develop the disorder following exposure to significant environmental stressors. Notably, studies on high-risk...
01:29Biological Causes of Schizophrenia
Schizophrenia, a severe psychiatric disorder, arises from a complex interplay of biological factors, including genetic predisposition, structural brain abnormalities, neurotransmitter dysregulation, and developmental irregularities. These factors collectively contribute to the onset and progression of the disorder, which typically manifests in late adolescence or early adulthood.
Genetic Factors in Schizophrenia
The genetic basis of schizophrenia is strongly supported by family and twin studies.
Genetic Factors in Schizophrenia
The genetic basis of schizophrenia is strongly supported by family and twin studies.
01:17Schizophrenia
Schizophrenia, a term introduced by Swiss psychiatrist Eugen Bleuler in 1911, describes a severe psychological disorder marked by profound disruptions in attention, thought processes, language, emotion, and interpersonal relationships. The core feature of schizophrenia is psychosis — a state characterized by a fundamental detachment from reality. This disconnection manifests through distorted logic, impaired perception, and atypical behavior, severely affecting the lives of those diagnosed.
01:27Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders
Schizophrenia is a neurodevelopmental disorder whose origins are rooted in complex genetic components. Despite our burgeoning understanding, the pathophysiology of this disorder remains incompletely deciphered.
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within the...
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within the...
01:30Negative and Cognitive Symptoms of Schizophrenia
Negative symptoms of schizophrenia indicate a reduction or absence of typical behaviors and emotional responses found in healthy individuals, while positive symptoms reflect an excess or distortion of normal functioning.
Negative Symptoms
Negative symptoms of schizophrenia manifest as deficits in normal emotional and behavioral functioning, profoundly impacting daily life. Individuals with schizophrenia often display a flat affect, characterized by a near-total absence of emotional expression,...
Negative Symptoms
Negative symptoms of schizophrenia manifest as deficits in normal emotional and behavioral functioning, profoundly impacting daily life. Individuals with schizophrenia often display a flat affect, characterized by a near-total absence of emotional expression,...
01:26Type II Diabetes I: Introduction
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...